SDHB and neoplasm: Several methods have been described to identify patients with tumors due to SDHx PVs, including ex vivo measurements of the succinate to fumarate ratio (SFR) in tumor tissue or the SDHB protein by immunohistochemistry as well as in situ detection of succinate by proton magnetic resonance spectroscopy [9].